» Articles » PMID: 9288968

PrP-expressing Tissue Required for Transfer of Scrapie Infectivity from Spleen to Brain

Overview
Journal Nature
Specialty Science
Date 1997 Sep 4
PMID 9288968
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Much available evidence points to a pathological isoform of the prion protein PrP being the infectious agent that causes transmissible spongiform encephalopathies, but the mechanisms controlling the neurotropism of prions are still unclear. We have previously shown that mice that do not express PrP (Prnp[o/o] mice) are resistant to infection by prions, and that if a Prnp(+/+) neurograft is introduced into such animals and these are infected intracerebrally with scrapie, the graft but not the surrounding tissue shows scrapie pathology. Here we show that PrP-expressing neurografts in Prnp(o/o) mice do not develop scrapie histopathology after intraperitoneal or intravenous inoculation with scrapie prions. Prion titres were undetectable in spleens of inoculated Prnp(o/o) mice, but were restored to wild-type levels upon reconstitution of the host lymphohaemopoietic system with PrP-expressing cells. Surprisingly, however, i.p. or i.v. inoculation failed to produce scrapie pathology in the neurografts of 27 out of 28 reconstituted animals, in contrast to intracerebral inoculation. We conclude that transfer of infectivity from the spleen to the central nervous system is crucially dependent on the expression of PrP in a tissue compartment that cannot be reconstituted by bone marrow transfer. Thus the requirement for the normal isoform of PrP in peripheral tissues represents a bottleneck for the spread of prions from peripheral sites to the central nervous system.

Citing Articles

Prion diseases disrupt glutamate/glutamine metabolism in skeletal muscle.

Caredio D, Koderman M, Frontzek K, Sorce S, Nuvolone M, Bremer J PLoS Pathog. 2024; 20(9):e1012552.

PMID: 39259763 PMC: 11419395. DOI: 10.1371/journal.ppat.1012552.


Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells.

Thellung S, Corsaro A, Bosio A, Zambito M, Barbieri F, Mazzanti M Cells. 2019; 8(11).

PMID: 31752162 PMC: 6912268. DOI: 10.3390/cells8111458.


Aβ Seeding as a Tool to Study Cerebral Amyloidosis and Associated Pathology.

Friesen M, Meyer-Luehmann M Front Mol Neurosci. 2019; 12:233.

PMID: 31632238 PMC: 6783493. DOI: 10.3389/fnmol.2019.00233.


Post-translational modifications in PrP expand the conformational diversity of prions in vivo.

Aguilar-Calvo P, Xiao X, Bett C, Erana H, Soldau K, Castilla J Sci Rep. 2017; 7:43295.

PMID: 28272426 PMC: 5341109. DOI: 10.1038/srep43295.


Prion disease: experimental models and reality.

Brandner S, Jaunmuktane Z Acta Neuropathol. 2017; 133(2):197-222.

PMID: 28084518 PMC: 5250673. DOI: 10.1007/s00401-017-1670-5.